FDA News
Most Popular FDA Story
FDA: Endo opioids may be mixed in Novartis OTC packages
The FDA has added its two cents to the Novartis ($NVS) consumer-drug recall. The agency has issued an advisory to healthcare professionals and patients that says some Endo Pharmaceuticals ($ENDP) Read more...
Latest Headlines
- February 3, 2012
- February 1, 2012
- January 11, 2012
- January 10, 2012
- January 3, 2012
- December 21, 2011
- December 20, 2011
- December 15, 2011
- December 14, 2011
- December 13, 2011
- December 12, 2011
- December 12, 2011
- December 8, 2011
- December 6, 2011
- November 29, 2011
- November 22, 2011
- November 14, 2011
- November 3, 2011
- November 2, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
